Serial Number
97898941
Owner
Hepalink USA Inc.Attorney
Gordon M. WrightFirst Use Date
Jan 1, 2014
Filing Date
Apr 20, 2023
Serial #97898941 Trademark
Serial Number: 97898941 • Registration: 7355281
Trademark Classes
Owner Contact Info
2005 Cabot Boulevard West, Suite 200
Langhorne, PA 190471885
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
April 20, 2023
Registration Date
April 9, 2024
First Use Anywhere
January 1, 2014
First Use in Commerce
January 1, 2014
Published for Opposition
January 23, 2024
Goods & Services
Manufacturing services for others in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds
Pharmaceutical products and preparations containing active pharmaceutical ingredients, namely, pharmaceutical grade Heparin Sodium, pharmaceutical grade Pancreatin, and pharmaceutical grade Pancrealipase, for use in humans and animals for the prevention and treatment of thrombotic events or to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparations, namely, anticoagulants; pharmaceutical products and preparations for the testing, sampling and identification of viruses, namely, medical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for treating thrombotic events and pancreatic insufficiency for use with medical devices for drug delivery; Pharmaceutical preparations for ophthalmological use, namely, for treating eye diseases and disorders
Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds